1. Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
   Anna Martinez-Cardús et al, 2009, Molecular Cancer Therapeutics CrossRef
2. Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy
   Klara Mladenić et al, 2021, Clinical Cancer Drugs CrossRef
3. Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells
   Ioanna Sigala et al, 2021, Cells CrossRef
4. Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas
   Gregory M. Hayes et al, 2007, Cancer Research CrossRef
5. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
   Ilias P. Nikas et al, 2019, Cells CrossRef
6. Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab
   Marie Prewett et al, 2007, Clinical Cancer Research CrossRef
7. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
   Eun-Kyung Kim et al, 2019, Antioxidants CrossRef
8. Good Cop, Bad Cop: The Different Roles of SRPKs
   Eleni Nikolakaki et al, 2022, Frontiers in Genetics CrossRef